XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.2.u1
INVESTMENTS AND FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2024
INVESTMENTS AND FAIR VALUE MEASUREMENTS  
INVESTMENTS AND FAIR VALUE MEASUREMENTS

 5.  INVESTMENTS AND FAIR VALUE MEASUREMENTS

We invest surplus funds in excess of operational requirements in a diversified portfolio of marketable securities, with the objectives of delivering competitive returns, maintaining a high degree of liquidity, and seeking to avoid the permanent impairment of principal. A summary of our investments in marketable equity and debt securities as of June 30, 2024, are as follows:


Investments - current were as follows (in thousands):

 

 


June 30, 2024


 


December 31, 2023


Marketable equity securities

$

57,171


 

$

  62,978


U.S. treasury securities


40,443


 


41,313


Short-term investments

$

97,614


 

$

104,291


Investments- noncurrent were as follows (in thousands):

 

 


June 30, 2024


 


December 31, 2023


U.S. treasury securities

$

   25,333


 

$

    13,653


Marketable debt securities


19,830


 


19,697


Investments- noncurrent

$

45,163


 

$

33,350


Marketable Securities

 

Marketable securities as of June 30, 2024 and December 31, 2023 consisted of the following (in thousands):

 



June 30, 2024




Cost or Amortized Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value

Marketable equity securities
















Equity securities

$

58,530



$

5,868



$

(7,227

)


$

57,171


Marketable debt securities
















U.S. treasury securities


64,816




976




(16

)



65,776


Corporate bonds


19,577




648




(395

)



19,830


Total marketable debt securities


84,393




 1,624




(411

)



 85,606



$

142,923



$

7,492



$

(7,638

)


$

142,777


 



December 31, 2023




Cost or Amortized Cost




Unrealized Gains




Unrealized Losses




Fair Value


Marketable equity securities
















Equity securities

$

 59,228



$

7,896



$

(4,146

)


$

62,978


Marketable debt securities
















U.S. treasury securities


53,662




1,307




(3

)



54,966


Corporate bonds


19,422




472




(197

)



19,697


Total marketable debt securities


 73,084




1,779




(200

)



74,663



$

132,312



$

 9,675



$

(4,346

)


$

 137,641



The amortized costs and fair value of our marketable debt securities, by contractual maturity, as of June 30, 2024 (in thousands) are as follows: 

 



June 30, 2024




Amortized Cost




Fair Value


Less than 1 year

$

 41,622



$

40,443


1 to 5 years


42,771




45,163


Total

$

 84,393



$

85,606



         As of June 30, 2024, the fair value of corporate bonds with unrealized loss position was $8.7 million, with an aggregated loss of $0.4 million. As June 30, 2024, the fair value of  U.S. treasury securities with unrealized loss position was $6.6 million, with an aggregated loss of $16,000. As of December 31, 2023, the fair value of available-for-sale debt securities in unrealized loss position for corporate bonds and U.S. treasury securities were $7.1 million and $2.7 million, respectively, with an aggregated loss of $0.2 million. For all available-for-sale debt securities that were in unrealized loss positions, we have determined that it is more likely than not we will hold the securities until maturity or a recovery of the cost basis. We had no credit-related impairment loss as of June 30, 2024 and December 31, 2023.


Derivative Financial Instruments

 

Our derivative instruments consisted of call and put options sold at their fair value as of the balance sheet date. These derivative instruments are reported as Other current liabilities on our Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 (in thousands):

 



June 30, 2024




Cost




Unrealized Losses




Fair Value


Derivative instruments

$

6,131



$

(842

)


$

5,289



$

6,131



$

(842

)


$

5,289


 



December 31, 2023




Cost




Unrealized Losses




Fair Value


Derivative instruments

$

8,797



$

(867

)


$

7,930



$

8,797



$

(867

)


$

7,930



A summary of realized and unrealized gains and losses from our equity securities and derivative instruments and realized gains and losses from our marketable debt securities are as follows (in thousands):

 



Three Months Ended June 30,




Six Months Ended June 30,



2024




2023




2024


2023

Net unrealized gains (losses) recognized on marketable equity securities

$

(2,453

)


$

(1,255

)
$ (5,108 )
$ 759

Net realized gains recognized on marketable equity securities


 3,703



4,561



9,182


6,230

Net unrealized losses recognized on derivative instruments


(2,844

)



(91

)

(26 )

(194 )

Net realized gains recognized on derivative instruments


3,327



1,520




2,893


2,237

Net realized gains recognized on marketable debt securities


473



217




555


217

Total net gains recognized in interest and other income (loss), net

$

 2,206


$

4,952


$ 7,496

$ 9,249


Fair Value Measurements

 

Our financial instruments include cash and cash equivalents, receivables, accrued liabilities and accounts payable. The fair value of cash and cash equivalents, receivables, accrued liabilities and accounts payable approximates their carrying values because of the short-term nature of these instruments, which are all considered Level 1. The fair value of long-term debt approximates its carrying value.

Our financial instruments measured at fair value on a recurring basis consisted of U.S. treasury securities, equity securities, corporate bonds and derivatives. U.S. treasury securities and equity securities are classified within Level 1 of the fair value hierarchy as they are valued based on quoted market price in an active market. Corporate bonds and derivative instruments are valued based on quoted prices in markets that are less active, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency are generally classified within Level 2 of the fair value hierarchy.

Financial instruments valued based on unobservable inputs which reflect the reporting entity’s own assumptions or data that market participants would use in valuing an instrument are generally classified within Level 3 of the fair value hierarchy. We did not hold Level 3 financial instruments as of June 30, 2024, and December 31, 2023.


Financial instruments measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2023 are classified based on the valuation technique in the table below (in thousands):

 



June 30, 2024








Fair Value Measurements Using








Quoted Prices in Active Markets for Identical Assets (Level 1)




Significant Other Observable Inputs (Level 2)




Significant Unobservable Inputs (Level 3)




Total


Assets:
















U.S. treasury securities 

$

 65,776



$

 —



$

 —



$

65,776


Equity securities


57,171




 —







 57,171


Corporate bonds


 —




 19,830







 19,830


Total assets at fair value

$

122,947



$

 19,830



$



$

142,777


















Liabilities
















Derivative instruments

$

 —



$

 5,289



$



$

5,289


Total liabilities at fair value

$

 —



$

 5,289



$



$

5,289


 



December 31, 2023








Fair Value Measurements Using








Quoted Prices in Active Markets for Identical Assets (Level 1)




Significant Other Observable Inputs (Level 2)




Significant Unobservable Inputs (Level 3)




Total


Assets:
















U.S. treasury securities

$

54,966



$

  —



$


$

54,966


Equity securities


 62,977







 —




 62,977


Corporate bonds





19,697




  —




19,697


Total assets at fair value

$

117,943



$

19,697



$



$

137,640


















Liabilities
















Derivative instruments

$

 —



$

 7,930



$

  —



$

  7,930


Total liabilities at fair value

$

 —



$

  7,930



$

 —



$

7,930